Superbowl bans medical cannabis ad
Superbowl LIV saw Kansas City defeat the San Francisco 49ers. The show attracted 102 million spectators and nearly $400 million in advertising revenue.
And while the booze hounds may have a field day during this extravagant show, some companies still don't have the right to screens.
In 2019, Acreage Holdings was denied airtime by CBS. The company was willing to put up $5 million for its spot, but CBS won't accept advertising for cannabis, even though Acreage's activities are legal in the countries where it operates.
The main aim of the advert was to encourage the legalization of medical marijuana at federal level.
The ad featured 3 people: a boy who had hundreds of epileptic seizures a day that were not alleviated by traditional treatments, a man addicted to opioids, and a veteran who was in great pain after his leg was amputated.
Everyone attested to the effect of cannabis on their quality of life.
Newsweed takes a look back at this touching commercial.
33 American states have legalized medical cannabis. The federal government has not yet legislated on the subject, but has authorized the sale of’a first cannabis-based medicine, Epidiolex, for people with epilepsy
-
Business2 weeks ago
Cronos Completes the Acquisition of CanAdelaar for 57.5 million euros
-
Cannabis in France3 weeks ago
France already has 3,000 cannabis retail outlets. None of them are legal.
-
Cannabis in Quebec1 week ago
Cannabis: What France Could Learn from Quebec, Eight Years After Legalization
-
Cannabis in the U.S.3 weeks ago
A DEA report confirms that there are no fatal cannabis overdoses
-
Studies on cannabis4 weeks ago
Cannabis Oil and Endometriosis: A Promising Study for Pain Relief
-
Cannabis in France3 weeks ago
CBD in France: Traceability, Retail Stores, THC and Driving… What the New Bill Proposes
-
Business3 weeks ago
Tilray is accelerating its operations in Europe thanks to a license in Portugal
-
CBD4 weeks ago
In Brazil, researchers are developing an innovative CBD eye drop


You must be logged in to post a comment Login